Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis ...
The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea ...
In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...
Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...
But phthalates have reportedly been linked to a number of health concerns, including birth defects, allergies in children and ...
Valenzuela told The American Journal of Managed Care® ( AJMC® ) that smart infrastructure and remote monitoring can make this ...
Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback